Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2020/08/17 | Phase 3 | Completed | Drugs for Neglected Diseases | ||
2020/04/09 | Phase 3 | Completed | |||
2017/09/26 | Phase 2 | Completed | Hospital Universitário Professor Edgard Santos | ||
2017/03/21 | Phase 2 | UNKNOWN | Infan Industria Quimica Farmaceutica Nacional | ||
2015/08/21 | Phase 2 | Active, not recruiting | University of Brasilia | ||
2013/10/01 | Phase 3 | Terminated | Hospital Universitário Professor Edgard Santos | ||
2011/11/03 | Phase 2 | Completed | Centro Internacional de Entrenamiento e Investigaciones Médicas | ||
2011/02/23 | Phase 2 | UNKNOWN | Oswaldo Cruz Foundation | ||
2011/02/23 | Phase 2 | Completed | Oswaldo Cruz Foundation | ||
2009/12/15 | Phase 4 | Completed | University of Brasilia |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
No FDA approvals found for this drug. |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No HSA approvals found for this drug. |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
---|---|---|---|---|---|
No TGA approvals found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.